Literature DB >> 18817771

Cellular localization of the activated EGFR determines its effect on cell growth in MDA-MB-468 cells.

Dustin C Hyatt1, Brian P Ceresa.   

Abstract

The epidermal growth factor (EGF) receptor (EGFR) is a ubiquitously expressed receptor tyrosine kinase that regulates diverse cell functions that are dependent upon cell type, the presence of downstream effectors, and receptor density. In addition to activating biochemical pathways, ligand stimulation causes the EGFR to enter the cell via clathrin-coated pits. Endocytic trafficking influences receptor signaling by controlling the duration of EGFR phosphorylation and coordinating the receptor's association with downstream effectors. To better understand the individual contributions of cell surface and cytosolic EGFRs on cell physiology, we used EGF that was conjugated to 900 nm polystyrene beads (EGF-beads). EGF-beads can stimulate the EGFR and retain the activated receptor at the plasma membrane. In MDA-MB-468 cells, a breast cancer cell line that over-expresses the EGFR, only internalized, activated EGFRs stimulate caspase-3 and induce cell death. Conversely, signaling cascades triggered from activated EGFR retained at the cell surface inhibit caspase-3 and promote cell proliferation. Thus, through endocytosis, the activated EGFR can differentially regulate cell growth in MDA-MB-468 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18817771      PMCID: PMC2590673          DOI: 10.1016/j.yexcr.2008.08.020

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  51 in total

1.  Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles.

Authors:  Wulf Schneider-Brachert; Vladimir Tchikov; Jens Neumeyer; Marten Jakob; Supandi Winoto-Morbach; Janka Held-Feindt; Michael Heinrich; Oliver Merkel; Martin Ehrenschwender; Dieter Adam; Rolf Mentlein; Dieter Kabelitz; Stefan Schütze
Journal:  Immunity       Date:  2004-09       Impact factor: 31.745

2.  Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system.

Authors:  Jennifer L Macdonald; Linda J Pike
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-28       Impact factor: 11.205

3.  Monensin, like methylamine, prevents degradation of 125I-epidermal growth factor, causes intracellular accumulation of receptors and blocks the mitogenic response.

Authors:  A C King
Journal:  Biochem Biophys Res Commun       Date:  1984-10-30       Impact factor: 3.575

4.  Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells.

Authors:  G N Gill; C S Lazar
Journal:  Nature       Date:  1981-09-24       Impact factor: 49.962

5.  Continual expression of Rab5(Q79L) causes a ligand-independent EGFR internalization and diminishes EGFR activity.

Authors:  Jennifer L Dinneen; Brian P Ceresa
Journal:  Traffic       Date:  2004-08       Impact factor: 6.215

6.  Synthesis, turnover, and down-regulation of epidermal growth factor receptors in human A431 epidermoid carcinoma cells and skin fibroblasts.

Authors:  M N Krupp; D T Connolly; M D Lane
Journal:  J Biol Chem       Date:  1982-10-10       Impact factor: 5.157

7.  Expression of dominant negative rab5 in HeLa cells regulates endocytic trafficking distal from the plasma membrane.

Authors:  Jennifer L Dinneen; Brian P Ceresa
Journal:  Exp Cell Res       Date:  2004-04-01       Impact factor: 3.905

8.  Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference.

Authors:  Fangtian Huang; Anastasia Khvorova; William Marshall; Alexander Sorkin
Journal:  J Biol Chem       Date:  2004-02-25       Impact factor: 5.157

9.  Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts.

Authors:  C M Stoscheck; G Carpenter
Journal:  J Cell Biol       Date:  1984-03       Impact factor: 10.539

10.  Local signaling by the EGF receptor.

Authors:  Stephan J Kempiak; Shu-Chin Yip; Jonathan M Backer; Jeffrey E Segall
Journal:  J Cell Biol       Date:  2003-09-01       Impact factor: 10.539

View more
  29 in total

1.  Nanoconjugation: A Materials Approach to Enhance Epidermal Growth Factor Induced Apoptosis.

Authors:  Linxi Wu; Xinwei Yu; Amin Feizpour; Björn M Reinhard
Journal:  Biomater Sci       Date:  2014-02-01       Impact factor: 6.843

2.  Distinct activation of epidermal growth factor receptor by UTP contributes to epithelial cell wound repair.

Authors:  Ilene Boucher; Amanuel Kehasse; Meredith Marcincin; Celeste Rich; Nader Rahimi; Vickery Trinkaus-Randall
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

3.  Regulation of keratinocyte signaling and function via changes in epidermal growth factor presentation.

Authors:  Tracy J Puccinelli; Paul J Bertics; Kristyn S Masters
Journal:  Acta Biomater       Date:  2010-04-14       Impact factor: 8.947

4.  Endosomal accumulation of the activated epidermal growth factor receptor (EGFR) induces apoptosis.

Authors:  Jamie S Rush; Leslie M Quinalty; Luke Engelman; David M Sherry; Brian P Ceresa
Journal:  J Biol Chem       Date:  2011-11-18       Impact factor: 5.157

5.  RIN1 orchestrates the activation of RAB5 GTPases and ABL tyrosine kinases to determine the fate of EGFR.

Authors:  Kavitha Balaji; Chelsea Mooser; Christine M Janson; Joanne M Bliss; Houmehr Hojjat; John Colicelli
Journal:  J Cell Sci       Date:  2012-09-12       Impact factor: 5.285

6.  Transforming growth factor-{alpha} enhances corneal epithelial cell migration by promoting EGFR recycling.

Authors:  Jennifer L McClintock; Brian P Ceresa
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-24       Impact factor: 4.799

7.  EGFR-mediated apoptosis via STAT3.

Authors:  Nicole M Jackson; Brian P Ceresa
Journal:  Exp Cell Res       Date:  2017-04-19       Impact factor: 3.905

8.  Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) × c-MET Antibodies and Antibody-Drug Conjugates.

Authors:  Carolin Sellmann; Achim Doerner; Christine Knuehl; Nicolas Rasche; Vanita Sood; Simon Krah; Laura Rhiel; Annika Messemer; John Wesolowski; Mark Schuette; Stefan Becker; Lars Toleikis; Harald Kolmar; Bjoern Hock
Journal:  J Biol Chem       Date:  2016-09-30       Impact factor: 5.157

9.  Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation.

Authors:  E Merit Reyes-Reyes; Francesca R Šalipur; Mitra Shams; Matthew K Forsthoefel; Paula J Bates
Journal:  Mol Oncol       Date:  2015-04-09       Impact factor: 6.603

10.  Ligand Density and Nanoparticle Clustering Cooperate in the Multivalent Amplification of Epidermal Growth Factor Receptor Activation.

Authors:  Qianyun Zhang; Björn M Reinhard
Journal:  ACS Nano       Date:  2018-10-11       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.